Atlas Trials

Drug-durg Interaction of SHR3680 With Digoxin, Rosuvastatin Calcium and Metformin Hydrochloride

Clinical trial NCT04621669 · COMPLETED

Trial details

NCT number
NCT04621669
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Drug-drug Interaction,SHR3680
Start date
2021-01-08
Primary completion
2021-09-08
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.